Daniel Busby
Stock Analyst at RBC Capital
(2.72)
# 2,120
Out of 5,045 analysts
6
Total ratings
66.67%
Success rate
22.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Busby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals | Downgrades: Sector Perform | $160 → $40 | $3.61 | +1,008.03% | 2 | May 25, 2022 | |
| PFE Pfizer | Maintains: Sector Perform | $43 → $44 | $24.29 | +81.14% | 1 | Jun 17, 2021 | |
| MNKD MannKind | Initiates: Sector Perform | $5 | $5.54 | -9.75% | 2 | May 14, 2021 | |
| ABBV AbbVie | Reiterates: Outperform | $135 | $225.14 | -40.04% | 1 | May 3, 2021 |
Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $160 → $40
Current: $3.61
Upside: +1,008.03%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43 → $44
Current: $24.29
Upside: +81.14%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $5.54
Upside: -9.75%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $225.14
Upside: -40.04%